TianYu Bio-Technology Co., Ltd. (SHA:603717)
China
· Delayed Price · Currency is CNY 7.21
-0.02 (-0.28%)
May 16, 2025, 2:45 PM CST
TianYu Bio-Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 801.51 | 668.39 | 940.87 | 633.77 | 579.52 | Upgrade
|
| Other Revenue | - | 2.06 | 4.04 | 4.31 | 3.02 | Upgrade
|
| Revenue | 801.51 | 670.45 | 944.91 | 638.08 | 582.54 | Upgrade
|
| Revenue Growth (YoY) | 19.55% | -29.05% | 48.09% | 9.53% | -30.43% | Upgrade
|
| Cost of Revenue | 714.68 | 990.07 | 859.29 | 588.92 | 520.65 | Upgrade
|
| Gross Profit | 86.83 | -319.62 | 85.62 | 49.16 | 61.89 | Upgrade
|
| Selling, General & Admin | 109.67 | 95.41 | 88.53 | 97.09 | 95.94 | Upgrade
|
| Research & Development | 11.61 | 13.91 | 26.38 | 10.37 | 12.92 | Upgrade
|
| Other Operating Expenses | 1.17 | 1.16 | 7.31 | 3.98 | 1.14 | Upgrade
|
| Operating Expenses | 122.45 | 114.56 | 354.38 | 283.67 | 145.16 | Upgrade
|
| Operating Income | -35.63 | -434.18 | -268.75 | -234.52 | -83.27 | Upgrade
|
| Interest Expense | - | -30.56 | -29.18 | -48.76 | -58.01 | Upgrade
|
| Interest & Investment Income | 0.21 | 11.67 | 19.71 | 37.52 | 18.84 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -34.82 | -0.51 | -31.16 | -9.28 | -5.45 | Upgrade
|
| EBT Excluding Unusual Items | -70.23 | -453.57 | -309.38 | -255.04 | -127.89 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.43 | -148.28 | -25.28 | - | -4.9 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.67 | 0.99 | 47.44 | 8.81 | 0.13 | Upgrade
|
| Asset Writedown | -15.84 | -14.97 | -1.4 | -0.41 | -33.66 | Upgrade
|
| Other Unusual Items | - | -4.05 | 9.48 | 10.94 | 3.56 | Upgrade
|
| Pretax Income | -87.16 | -617.16 | -278.22 | -235.7 | -160.76 | Upgrade
|
| Income Tax Expense | -0.32 | -18.48 | -42.51 | -15.14 | -2.17 | Upgrade
|
| Earnings From Continuing Operations | -86.84 | -598.68 | -235.71 | -220.56 | -158.6 | Upgrade
|
| Minority Interest in Earnings | -20.51 | 104.25 | -43.7 | 5.82 | 1.15 | Upgrade
|
| Net Income | -107.36 | -494.43 | -279.41 | -214.74 | -157.45 | Upgrade
|
| Net Income to Common | -107.36 | -494.43 | -279.41 | -214.74 | -157.45 | Upgrade
|
| Shares Outstanding (Basic) | 290 | 290 | 242 | 266 | 242 | Upgrade
|
| Shares Outstanding (Diluted) | 290 | 290 | 242 | 266 | 242 | Upgrade
|
| Shares Change (YoY) | 0.01% | 19.99% | -9.09% | 9.99% | 0.00% | Upgrade
|
| EPS (Basic) | -0.37 | -1.70 | -1.16 | -0.81 | -0.65 | Upgrade
|
| EPS (Diluted) | -0.37 | -1.70 | -1.16 | -0.81 | -0.65 | Upgrade
|
| Free Cash Flow | 81.27 | -260.48 | 22.19 | -230.25 | -164.38 | Upgrade
|
| Free Cash Flow Per Share | 0.28 | -0.90 | 0.09 | -0.87 | -0.68 | Upgrade
|
| Gross Margin | 10.83% | -47.67% | 9.06% | 7.70% | 10.62% | Upgrade
|
| Operating Margin | -4.45% | -64.76% | -28.44% | -36.75% | -14.29% | Upgrade
|
| Profit Margin | -13.39% | -73.75% | -29.57% | -33.66% | -27.03% | Upgrade
|
| Free Cash Flow Margin | 10.14% | -38.85% | 2.35% | -36.09% | -28.22% | Upgrade
|
| EBITDA | 2.35 | -401.77 | -254.23 | -220.24 | -69.56 | Upgrade
|
| EBITDA Margin | 0.29% | -59.92% | -26.91% | -34.52% | -11.94% | Upgrade
|
| D&A For EBITDA | 37.98 | 32.41 | 14.52 | 14.27 | 13.71 | Upgrade
|
| EBIT | -35.63 | -434.18 | -268.75 | -234.52 | -83.27 | Upgrade
|
| EBIT Margin | -4.45% | -64.76% | -28.44% | -36.75% | -14.29% | Upgrade
|
| Revenue as Reported | - | 670.45 | 944.91 | 638.08 | - | Upgrade
|
| Advertising Expenses | - | 0.02 | 0.01 | 0.25 | 0.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.